Top compounds associated with response to LRRC36


Feature Type Standardized
Nominal ANOVA
mRNA Pazopanib FIMM pan-cancer AAC 0.2 0.3
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.041 0.3
mRNA IOX2 GDSC1000 pan-cancer AAC -0.036 0.3
mRNA BRD-K71781559 CTRPv2 pan-cancer AAC -0.042 0.3
mRNA QW-BI-011 CTRPv2 pan-cancer AAC 0.072 0.3
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.04 0.3
mRNA Cisplatin GDSC1000 pan-cancer AAC 0.036 0.3
mRNA piperlongumine GDSC1000 pan-cancer AAC 0.034 0.3
mRNA thalidomide CTRPv2 pan-cancer AAC -0.058 0.3
mRNA pluripotin CTRPv2 pan-cancer AAC -0.037 0.3
Download CSV